1. What Belmazol 40 mg is and what it is used for
2. What you need to know before you start taking Belmazol 40 mg
3. How to take Belmazol 40 mg
4. Possible side effects
5. Storage of Belmazol 40 mg
6. Contents of the pack and additional information
Belmazol contains the active ingredient omeprazole. It belongs to a group of medicines called “proton pump inhibitors”. These medicines work by reducing the amount of acid produced by the stomach.
Belmazol is used to treat the following diseases:
In adults:
In children:
Children over 1 year of age and = 10 kg
In children, symptoms of the disease may include the return of stomach contents to the mouth (regurgitation), vomiting, and inadequate weight gain.
Children over 4 years of age and adolescents
Ulcers infected by a bacteria called “Helicobacter pylori”. If your child has this disease, it is possible that your doctor will prescribe antibiotics to treat the infection and allow the ulcer to heal.
Do not take Belmazol
If you are unsure, consult your doctor or pharmacist before taking Belmazol 40 mg hard-gastrorresistent capsules.
Warnings and precautions
Belmazol may mask the symptoms of other diseases. Therefore, if you experience any of the following symptoms before starting Belmazol or during treatment, consult your doctor immediately if:
When taking omeprazole, it may cause inflammation in the kidneys. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
If you take Belmazol for a long period (more than 1 year), your doctor will likely perform regular check-ups. Inform your doctor of any new or unusual symptoms and circumstances whenever you visit.
If you are taking proton pump inhibitors such as omeprazole, especially for more than a year, it may slightly increase the risk of hip, wrist, and spinal fractures. Inform your doctor if you have osteoporosis or are taking corticosteroids (which may increase the risk of osteoporosis).
Omeprazole may interfere with some diagnostic tests (cromogranina A). To avoid these interferences, omeprazole treatment should be suspended at least five days before the measurement.
Taking Belmazol with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. Belmazol may affect the mechanism of action of some medications and some medications may affect Belmazol.
Do not take Belmazol if you are taking a medication that containsnelfinavir(used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medications:
If your doctor has prescribed you the antibiotics amoxicillin and clarithromycin to treat ulcers caused byHelicobacter pyloriinfection, it is very important to inform your doctor of any other medications you are taking.
Taking Belmazol with food and drinks
You can take your capsules with food or on an empty stomach.
Fertility, pregnancy, and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication. Your doctor will decide if you can take Belmazol during this time.
Omeprazole passes into breast milk but is unlikely to affect the baby when used in therapeutic doses. Your doctor will decide if you can take Belmazol while breastfeeding.
Driving and operating machinery
Belmazol is unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or operate machinery.
Belmazol contains saccharose and sodium
This medication contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Belmazol contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age.
The usual doses are indicated below.
Adults:
Treatment of symptoms of gastroesophageal reflux disease (GERD), such asheartburn and acid regurgitation:
Treatment ofulcers in the upper part of the intestine (duodenal ulcer):
Treatment ofstomach ulcers (gastric ulcer):
Preventionof the recurrence ofstomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused bynonsteroidal anti-inflammatory drugs (NSAIDs):
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriandprevention of its recurrence:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Use in children:
Treatment of symptoms of gastroesophageal reflux disease (GERD), such asheartburn and acid regurgitation
Treatment ofulcers causedby the infectionbyHelicobacter pyloriand prevention of its recurrence:
How to take this medication
What to do if you or your child have trouble swallowing the capsules
If you take more Belmazol than you should
If you have taken more Belmazol than prescribed by your doctor, consult your doctor or pharmacist immediately. You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Belmazol
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
Like all medications, this medication may cause side effects, although not everyone will experience them.
If you experience any of the following side effects, contact your doctor or go to the hospital immediately:
Other side effects are:
Frequent side effects (may affect up to 1 in 10 people)
Rare side effects (may affect up to 1 in 100 people)
Very rare side effects (may affect up to 1 in 10,000 people)
In rare cases, omeprazole may affect white blood cells in the blood and cause immunodeficiency. If you have an infection with symptoms such as fever with a very poor general condition or fever with local infection symptoms, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a white blood cell deficiency (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Unknown frequency (cannot be estimated from available data)
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: http;//www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C.
Keep the bottle perfectly closed to protect it from moisture.
Medications should not be thrown down the drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Belmazol 40 mg hard-gastrorresistant capsules
The capsule is composed of: erythrosine (E127), indigo carmine (E132), titanium dioxide (E171), gelatin, quinoline yellow (E104).
Printing ink:Shellac, propylene glycol, sodium hydroxide, polyvinylpyrrolidone, titanium dioxide (E171).
Appearance of the product and content of the container
Belmazol 40 mg capsules are formed by a orange-colored body marked with a "40" and a blue-colored cap marked with "O", containing white-beige-colored omeprazole microgranules.
Container sizes:
HDPE bottles with 14 and 28 capsules.
Blister packs of 14 and 28 capsules.
Only some container sizes may be commercially available.
Marketing authorization holder and responsible manufacturer:
Marketing authorization holder:
TEVA PHARMA, S.L.U.
C/ Anabel Segura 11. Edificio Albatros B, 1st floor.
28108 Alcobendas. Madrid
Spain
Responsible manufacturer
TEVA PHARMA, S.L.U.
Polígono Malpica, Calle C nº 4.
50016 Zaragoza.
Spain
Last review date of this leaflet:March 2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.